iotaMotion, Inc.

Advancing CI Surgery: Robotic Precision for Electrode Array Insertion.

iotaMotion, Inc. iotaMotion is standardizing CI electrode array insertion with iotaSOFT®, an open-platform robotic-assisted electrode array insertion system compatible with all three CI manufacturers. By controlling insertion at speeds beyond human capability, the iotaSOFT System can reduce surgical variability and intracochlear trauma—addressing several key patient concerns.

Clinical Evidence: The iotaSOFT Advantage
A landmark study in The Laryngoscope (Khan et al., 2026) highlights the clinical superiority of robotic-assisted insertion over manual techniques for long-term hearing outcomes.

Key Findings at One-Year Post-Op:

Superior Preservation: 85% of the robotic-assisted group maintained functional acoustic hearing, compared to 71% in the manual group.
Enhanced Stability: Robotic insertion reduced Delayed-Onset Hearing Loss (DOHL) by nearly one-third, suggesting that precise, controlled insertion mitigates long-term intracochlear trauma.

Why It Matters for Audiologists
As candidacy expands, robotic assistance helps bridge the gap for the 60 million individuals worldwide with severe-to-profound impairment who may fear losing residual natural hearing.

Manufacturer Agnostic: Compatible with all three major CI manufacturers.
Proven Scale: Utilized in over 1,300 cases across 35+ centers nationwide.
Expanded Access: Now FDA-cleared for patients ages four and older.

By utilizing the iotaSOFT Insertion System, clinics can offer a more predictable physiological outcome, directly addressing some of the primary barriers to CI adoption. Please visit our website, review our Clinical Evidence Summary or reach out to us at: [email protected].

*World Health Organization (WHO). iotaMotion Data on File.

Continuing Education

1 https://www.audiologyonline.com/audiology-ceus/course/robot-walks-into-ci-center-42190 A Robot Walks into a CI Center: What Audiologists Need to Know about iotaSOFT, Including Counseling Tips In this course, participants will learn about the iotaSOFT CI electrode array insertion system, relevant and emerging patient outcomes data, and how this technology can help patients move forward with a CI sooner. Special emphasis will be given to pediatric populations and the decisions parents face when choosing a CI for their child(ren) and how iotaSOFT can help them gain confidence in their decision. New data on patient preferences will also be shared. auditory, textual, visual 129 USD Subscription Unlimited COURSE Access for $129/year OnlineOnly AudiologyOnline www.audiologyonline.com A Robot Walks into a CI Center: What Audiologists Need to Know about iotaSOFT, Including Counseling Tips In this course, participants will learn about the iotaSOFT CI electrode array insertion system, relevant and emerging patient outcomes data, and how this technology can help patients move forward with a CI sooner. Special emphasis will be given to pediatric populations and the decisions parents face when choosing a CI for their child(ren) and how iotaSOFT can help them gain confidence in their decision. New data on patient preferences will also be shared. 42190 Online PT60M

A Robot Walks into a CI Center: What Audiologists Need to Know about iotaSOFT, Including Counseling Tips

Presented by Camille Dunn, PhD, CCC-A

Mon, Jun 1, 2026 at 12:00 pm EDT

Course: #42190Level: Intermediate1 Hour

View CEUs/Hours Offered

In this course, participants will learn about the iotaSOFT CI electrode array insertion system, relevant and emerging patient outcomes data, and how this technology can help patients move forward with a CI sooner. Special emphasis will be given to pediatric populations and the decisions parents face when choosing a CI for their child(ren) and how iotaSOFT can help them gain confidence in their decision. New data on patient preferences will also be shared.

2 https://www.audiologyonline.com/audiology-ceus/course/robotic-assisted-cochlear-implant-ci-41931 Robotic-Assisted Cochlear Implant (CI) Procedures Are Here As CI criteria expand, the focus has shifted from simple placement to preserving delicate intracochlear structures and residual hearing. iotaSOFT® is the first and only FDA-cleared robotic-assisted cochlear implant electrode array insertion system designed to reduce trauma in patients 4 years and older.Recent data indicate that robotic-assisted insertion is superior in maintaining long-term, stable hearing across different manufacturers, with an 85% hearing preservation rate compared to 71% in manual cases (Khan, et. al, 2026). The robotic cohort demonstrated significantly lower rates of delayed-onset hearing loss (DOHL), suggesting that the precision of a controlled insertion reduces intracochlear trauma. Robotic insertion reduced DOHL by nearly one-third. Join our course to explore how the iotaSOFT system: Standardizes the most critical surgical step with sub-millimeter precision; Delivers superior, long-term hearing outcomes; and Drives program growth by transforming patient apprehension into action. auditory, textual, visual 129 USD Subscription Unlimited COURSE Access for $129/year OnlineOnly AudiologyOnline www.audiologyonline.com Robotic-Assisted Cochlear Implant (CI) Procedures Are Here As CI criteria expand, the focus has shifted from simple placement to preserving delicate intracochlear structures and residual hearing. iotaSOFT® is the first and only FDA-cleared robotic-assisted cochlear implant electrode array insertion system designed to reduce trauma in patients 4 years and older.Recent data indicate that robotic-assisted insertion is superior in maintaining long-term, stable hearing across different manufacturers, with an 85% hearing preservation rate compared to 71% in manual cases (Khan, et. al, 2026). The robotic cohort demonstrated significantly lower rates of delayed-onset hearing loss (DOHL), suggesting that the precision of a controlled insertion reduces intracochlear trauma. Robotic insertion reduced DOHL by nearly one-third. Join our course to explore how the iotaSOFT system: Standardizes the most critical surgical step with sub-millimeter precision; Delivers superior, long-term hearing outcomes; and Drives program growth by transforming patient apprehension into action. 41931 Online PT60M

Robotic-Assisted Cochlear Implant (CI) Procedures Are Here

Presented by Alyson Schapira, AuD

Course: #41931Level: Introductory1 Hour

83 Reviews

View CEUs/Hours Offered

As CI criteria expand, the focus has shifted from simple placement to preserving delicate intracochlear structures and residual hearing. iotaSOFT® is the first and only FDA-cleared robotic-assisted cochlear implant electrode array insertion system designed to reduce trauma in patients 4 years and older.

Recent data indicate that robotic-assisted insertion is superior in maintaining long-term, stable hearing across different manufacturers, with an 85% hearing preservation rate compared to 71% in manual cases (Khan, et. al, 2026). The robotic cohort demonstrated significantly lower rates of delayed-onset hearing loss (DOHL), suggesting that the precision of a controlled insertion reduces intracochlear trauma. Robotic insertion reduced DOHL by nearly one-third.

Join our course to explore how the iotaSOFT system: Standardizes the most critical surgical step with sub-millimeter precision; Delivers superior, long-term hearing outcomes; and Drives program growth by transforming patient apprehension into action.

More iotaMotion, Inc. Continuing Education Events

Videos

The iotaMotion Advantage: iotaSOFT® Robotic-Assisted Cochlear Implant Insertion System

March 9, 2026

The iotaSOFT® Robotic-Assisted Cochlear Implant Insertion System is designed to preserve delicate intracochlear structures through a slow, consistent, and controlled electrode array insertion, adv...

Watch Video

News

iotaMotion Receives FDA Clearance for Expanded Pediatric Use of iotaSOFT® Robotic-Assisted Cochlear Implant Insertion System
February 10, 2026 iotaMotion, Inc., creator of iotaSOFT®, the first and only FDA-cleared robotic-assisted cochlear implant insertion system, today announced U.S. Food and Drug Administration (FDA) 510(k) clearance for expanded pediatric use of its iotaSOFT® Insertion System.

Ask the Expert

How does robotic-assisted cochlear implant electrode insertion reduce intracochlear trauma and support better hearing outcomes?
April 24, 2026 Sara Ashburn-Reed, Alyson Schapira, AuD How does robotic-assisted cochlear implant electrode insertion reduce intracochlear trauma and support better hearing outcomes?

Resources

iotaSOFT® Insertion System

World’s first FDA-authorized robotic-assisted electrode array insertion technology.

March 11, 2026

Robotic-Assisted Electrode Array Insertion Improves Stability of Acoustic Hearing Thresholds

Robotic-assisted electrode array (EA) insertion is a promising technique that may enhance preservation of residual acoustic hearing after cochlear implant (CI) surgery. The purpose of this study is to evaluate the impact of robotic-assisted EA insert

March 10, 2026

Understanding your Hearing Loss Options

Cochlear implants can help you connect with the world around you.